Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Vopr Onkol ; 44(3): 300-3, 1998.
Article in Russian | MEDLINE | ID: mdl-9695776

ABSTRACT

The investigation deals with a simplified modification or molecular-genetic detection of translocation t(9;22) using a combination of reverse transcription and polymerase chain reactions (RT-PCR). Unlike the available protocols, analysis is carried out using one enzyme--TET-Z polymerase--(instead of two) which has both revertase and DNA-polymerase activities. The present modification is highly sensitive, less time-consuming and cheaper. The method has proved useful for both diagnosing t(9;22) translocation and diagnosing and monitoring minimal residual disease remaining after marrow transplantation.


Subject(s)
Chromosomes, Human, Pair 22/genetics , Chromosomes, Human, Pair 9/genetics , Neoplasm, Residual/diagnosis , Neoplasm, Residual/genetics , Polymerase Chain Reaction , Translocation, Genetic , Humans , Polymerase Chain Reaction/methods , RNA-Directed DNA Polymerase
2.
Ter Arkh ; 68(7): 27-31, 1996.
Article in Russian | MEDLINE | ID: mdl-8928068

ABSTRACT

To elucidate feasibility of accurate diagnosis of chronic myeloid leukemia (CML) without cytogenetic and molecular-genetic investigations as well as to specify CML diagnostic criteria, clinicohematological parameters were compared in two groups of patients: with Ph'-chromosome and/or rearrangement of fragment bcr (group 1), with unknown karyotype in whom detection of bcr fragment rearrangement was not made. Clinicohematological parameters in both groups were close in absolute value and underwent parallel changes in the course of leukemia progression. In group 1, patients in progressive and blastic phase compared to patients in chronic phase had a 14-fold increase in the number of additional cytogenetic anomalies. In patients with tumor transformation fragment bcr underwent rearrangement according to type B2A2. Thus, the diagnosis of typical CML variants is feasible without detection of Ph'-chromosome and/or rearrangement of bcr fragment. It is especially true and essential for patients in the chronic phase. The data obtained provide more accurate diagnostic criteria of CML.


Subject(s)
Leukemia, Myelogenous, Chronic, BCR-ABL Positive/diagnosis , Adolescent , Adult , Aged , Bone Marrow/ultrastructure , Disease Progression , Hepatomegaly/diagnosis , Humans , Karyotyping , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/blood , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/genetics , Middle Aged , Polymerase Chain Reaction , Splenomegaly/diagnosis , Tumor Cells, Cultured
3.
Vestn Ross Akad Med Nauk ; (4): 20-5, 1993.
Article in Russian | MEDLINE | ID: mdl-7687479

ABSTRACT

The authors studied spontaneous DNA damages and the extra plan synthesis of DNA in various leukemias (chronic lympholeukemia, chronic myeloleukemia, acute leukemia) to predict the natural course of leukemias and the efficiency of chemotherapy. The level of genuine DNA breaks, which had been determined by the nic-translation test, was lower in peripheral blood cell DNA in all leukemias than that in the lymphocytes and granulocytes from donors. On the contrary, the levels of alkaline-labile DNA sites and nuclear matrix protein-bound DNA in the mature and maturing leukemia cells are high and decrease with progression of chronic lympholeukemia and chronic myeloleukemia. The extra plan DNA synthesis largely reflects the cellular levels of genuine DNA breaks, and the ultraviolet-induced DNA repair capacity is the highest in the lymphocytes in chronic lympholeukemia and particularly in the blasts in acute leukemia. The efficiency of chemotherapy was predicted during chemotherapy from the intensity of formation of genuine blast cell DNA breaks.


Subject(s)
Antineoplastic Agents/therapeutic use , DNA Damage , DNA, Neoplasm/drug effects , Leukemia/blood , Leukocytes/drug effects , DNA Repair/drug effects , DNA Repair/radiation effects , DNA, Neoplasm/blood , DNA, Neoplasm/radiation effects , DNA, Single-Stranded/blood , DNA, Single-Stranded/drug effects , DNA, Single-Stranded/radiation effects , Drug Screening Assays, Antitumor , Humans , Leukemia/drug therapy , Leukocytes/metabolism , Leukocytes/radiation effects , Prognosis , Tumor Cells, Cultured/drug effects , Tumor Cells, Cultured/metabolism , Tumor Cells, Cultured/radiation effects , Ultraviolet Rays
SELECTION OF CITATIONS
SEARCH DETAIL
...